HLX04-O (bevacizumab biosimilar) - Fosun Pharma, Essex Bio-Technology
Lucentis (ranibizumab) - Roche, Novartis
http://clinicaltrials.gov/ct2/show/NCT04740671
 
Apr 17, 2024
 
Next